A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...] …
Year: 2024
Influential Republican lawmakers have introduced companion bills in the U.S. House and Senate that call for a government report on [...] …
340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’
A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...] …
New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...] …
A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...] …
Medicare administrative contractors (MACs) covering more than half the states have initiated lump sum repayments to 340B hospitals, after getting [...] …
An influential senator’s inquiry into the nation’s two largest 340B pharmacy chains comes amid growing scrutiny into 340B contract pharmacies [...] …
Pharmaceutical giant AbbVie recently urged a federal judge to rule on its suit against Louisiana’s 340B contract pharmacy law without [...] …

Q: Tell us some interesting details about your company’s history.
Imagine a world where flip phones were the pinnacle of consumer technology – that’s the era when RxStrategies was founded.
…
The top Republican on an influential Senate committee yesterday asked the nation’s two largest contract pharmacy companies for detailed information [...] …